118 related articles for article (PubMed ID: 21753765)
1. Genetic analysis of contiguous X-chromosome deletion syndrome encompassing the BTK and TIMM8A genes.
Arai T; Zhao M; Kanegane H; van Zelm MC; Futatani T; Yamada M; Ariga T; Ochs HD; Miyawaki T; Oh-ishi T
J Hum Genet; 2011 Aug; 56(8):577-82. PubMed ID: 21753765
[TBL] [Abstract][Full Text] [Related]
2. Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes.
Sedivá A; Smith CI; Asplund AC; Hadac J; Janda A; Zeman J; Hansíková H; Dvoráková L; Mrázová L; Velbri S; Koehler C; Roesch K; Sullivan KE; Futatani T; Ochs HD
J Clin Immunol; 2007 Nov; 27(6):640-6. PubMed ID: 17851739
[TBL] [Abstract][Full Text] [Related]
3. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
Front Immunol; 2020; 11():2001. PubMed ID: 33013854
[No Abstract] [Full Text] [Related]
4. Phenotype prediction of Mohr-Tranebjaerg syndrome (MTS) by genetic analysis and initial auditory neuropathy.
Wang H; Wang L; Yang J; Yin L; Lan L; Li J; Zhang Q; Wang D; Guan J; Wang Q
BMC Med Genet; 2019 Jan; 20(1):11. PubMed ID: 30634948
[TBL] [Abstract][Full Text] [Related]
5. Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions.
Rohrer J; Minegishi Y; Richter D; Eguiguren J; Conley ME
Clin Immunol; 1999 Jan; 90(1):28-37. PubMed ID: 9884350
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of deletion breakpoints in four Mohr-Tranebjærg syndrome (MTS) patients.
Rendtorff ND; Karstensen HG; Lodahl M; Tolmie J; McWilliam C; Bak M; Tommerup N; Nazaryan-Petersen L; Kunst H; Wong M; Joss S; Carelli V; Tranebjærg L
Sci Rep; 2022 Sep; 12(1):14959. PubMed ID: 36056138
[TBL] [Abstract][Full Text] [Related]
7. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
Fiorini M; Franceschini R; Soresina A; Schumacher RF; Ugazio AG; Rossi P; Plebani A; Notarangelo LD
Hum Mutat; 2004 Mar; 23(3):286. PubMed ID: 14974089
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
[TBL] [Abstract][Full Text] [Related]
9. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome.
Ha AD; Parratt KL; Rendtorff ND; Lodahl M; Ng K; Rowe DB; Sue CM; Hayes MW; Tranebjaerg L; Fung VS
Mov Disord; 2012 Jul; 27(8):1034-40. PubMed ID: 22736418
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency.
Stewart DM; Notarangelo LD; Kurman CC; Staudt LM; Nelson DL
J Immunol; 1995 Sep; 155(5):2770-4. PubMed ID: 7650402
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
13. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
[TBL] [Abstract][Full Text] [Related]
14. Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.
Jo EK; Wang Y; Kanegane H; Futatani T; Song CH; Park JK; Kim JS; Kim DS; Ahn KM; Lee SI; Park HJ; Hahn YS; Lee JH; Miyawaki T
J Hum Genet; 2003; 48(6):322-326. PubMed ID: 12768435
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome.
Neighbors A; Moss T; Holloway L; Yu SH; Annese F; Skinner S; Saneto R; Steet R
Mol Genet Genomic Med; 2020 Mar; 8(3):e1121. PubMed ID: 31903733
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
Kristufek D; Aspalter RM; Eibl MM; Wolf HM
Mol Immunol; 2007 Mar; 44(7):1639-43. PubMed ID: 17045652
[TBL] [Abstract][Full Text] [Related]
17. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
Hagemann TL; Rosen FS; Kwan SP
Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
[TBL] [Abstract][Full Text] [Related]
18. Xq22.1 contiguous gene deletion syndrome of X-linked agammaglobulinemia and Mohr-Tranebjærg syndrome.
Shaker M; Lorigiano TH; Vadlamudi A
Ann Allergy Asthma Immunol; 2016 Jun; 116(6):578-9. PubMed ID: 27048950
[No Abstract] [Full Text] [Related]
19. The syndrome of deafness-dystonia: clinical and genetic heterogeneity.
Kojovic M; Pareés I; Lampreia T; Pienczk-Reclawowicz K; Xiromerisiou G; Rubio-Agusti I; Kramberger M; Carecchio M; Alazami AM; Brancati F; Slawek J; Pirtosek Z; Valente EM; Alkuraya FS; Edwards MJ; Bhatia KP
Mov Disord; 2013 Jun; 28(6):795-803. PubMed ID: 23418071
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
